Interestingly, the use of the sodium glucose cotransporter 2 inhibitor, canagliflozin has resulted in an increase in Lachnospiraceae UCG-001 abundance in diabetic mice and in improved kidney outcomes in patients with CKD and type 2 diabetes.40 The gene discussed is SLC5A2; the disease is chronic kidney disease.